Researchers at Oregon Health & Science University have developed the first transgenic nonhuman primate model—genetically modified to carry a human gene—for studying hepatitis B virus. The breakthrough could lead to the development of new treatments for the disease, which affects about 250 million people globally and results in nearly 1 million deaths annually.
First transgenic primate model created for hepatitis B research
